Pneumonia News and Research

Latest Pneumonia News and Research

UC Davis pediatricians describe challenges faced by children with asthma in California

UC Davis pediatricians describe challenges faced by children with asthma in California

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Researchers identify fast and accurate approach to diagnose respiratory tract infection

Researchers identify fast and accurate approach to diagnose respiratory tract infection

Statins benefit patients undergoing major lung resection, lower major complications

Statins benefit patients undergoing major lung resection, lower major complications

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

New research examines antibiotic choice for treating children with community-acquired pneumonia

New research examines antibiotic choice for treating children with community-acquired pneumonia

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Certain anti-nausea medications used after operation could increase risk for irregular heartbeat

Certain anti-nausea medications used after operation could increase risk for irregular heartbeat

Promising results for multi-source DBS in Parkinson’s disease

Promising results for multi-source DBS in Parkinson’s disease

Researchers uncover how Gram-negative bacteria can trigger immune system reaction

Researchers uncover how Gram-negative bacteria can trigger immune system reaction

Patients with community-acquired pneumonia have high rates of long-term morbidity and mortality

Patients with community-acquired pneumonia have high rates of long-term morbidity and mortality

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Common antibiotic azithromycin effectively kills many multidrug-resistant bacteria

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Withholding ARBs for longer than two days after surgery significantly increases risk of postoperative death

Withholding ARBs for longer than two days after surgery significantly increases risk of postoperative death

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

Delirium in ICU associated with lengthier hospital stays and greater risk of death

Delirium in ICU associated with lengthier hospital stays and greater risk of death

Transitional and progressive care can help patients achieve functional recovery faster in post-acute care

Transitional and progressive care can help patients achieve functional recovery faster in post-acute care

ASCO 2015: AMGEN presents new data evaluating less-frequent dosing of kyprolis for multiple myeloma patients

ASCO 2015: AMGEN presents new data evaluating less-frequent dosing of kyprolis for multiple myeloma patients

ASCO 2015: AMGEN presents new data evaluating less-frequent dosing of kyprolis for multiple myeloma patients

ASCO 2015: AMGEN presents new data evaluating less-frequent dosing of kyprolis for multiple myeloma patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.